COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,151 Articles (22,701 medRxiv, 8,450 bioRxiv)

Most recent first Previous |  Page 10: Articles 91-100  | Next

Long COVID Longitudinal Symptoms Burden Clusters Within A National Community-Based Cohort
Shen, Y., Shahn, Z., Robertson, M., Gebo, K., Nash, D.
10.1101/2025.11.01.25339283 — Posted: 2025-11-04
Persistent Classical and Atypical Memory B Cells Underlie Heterogeneous Vaccine Responses in Ocrelizumab-Treated Multiple Sclerosis
Curtin, R., Velmurugu, Y., Dibba, F., Hao, Y., Sreenivasaiah, C., Khodadadi-Jamayran, A., Nyovanie, S. T., Kim, A., Samanovic-Golden, M., Mulligan, M. J., Priest, J., Cabatingan, M., Winger, R., Patskovsky, Y., Kister, I., Silverman, G. J., Krogsgaard, M.
10.1101/2025.11.03.686372 — Posted: 2025-11-04
The coronavirus envelope is conserved, contains bioactive lipids needed for replication, and is modulated in response to host inflammation
Tyrrell, V., Zaragkoulias, A., Powell, W., Elfar, M., Grossoni, V., Monaco, F., Protty, M., Stenhouse, E., Heyman, J., Costa, D., Roche, L., Lynch, C.-A. B., Ghazal, P., Jones, S. A., Lambeau, G. A., Benatzy, Y., Kandler, J., Bojkova, D., Snodgrass, R., Brune, B., Thomas, D., Stanton, R., O'Donnell, V.
10.1101/2025.11.03.686211 — Posted: 2025-11-03
Tracking the opening of spike crowns on the surface of coronaviruses
Wu, D.
10.1101/2025.11.02.686173 — Posted: 2025-11-03
Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection
ELTOBGY, M., Shamseldin, M., Whitham, O., Amer, H., Atkinson, J., Badr, A., Hall, J., Omran, J., Gupta, G., Hassan, Y., Abdelaleem, R., Perez, R., Faber, S., Pietrzak, M., Webb, A., Zhang, X., Kenney, A., Bissel, D., Estfanous, S., Daily, K., Mcnamara, A., KC, M., Peeples, M., Hemann, E., Nimjee, S., Cormet-Boyaka, E., Li, J., Boyaka, P., Yount, J., Segal, B., Dubey, P., Amer, A.
10.1101/2025.11.01.684729 — Posted: 2025-11-03
Neutral Frustration Landscape Architecture of SARS-CoV-2 Spike -Antibody Interfaces Shapes Immune Evasion Mechanisms for Ultrapotent Neutralizing Antibodies and Determines Pathways of Viral Adaptation: Insights from Integrative Computational Approach
Alshahrani, M., Parikh, V., Foley, B., Verkhivker, G.
10.1101/2025.10.31.685956 — Posted: 2025-11-03
In vitro Characterization of Peptidomimetic Proteolysis Targeting Chimera (PROTAC) as a Degrader of 3-Chymotrypsin-Like Protease (Mpro/3CLpro) against SARS-CoV-2
Liturri, M. G., Bergna, A., Lai, A., Della Ventura, C., Gabrieli, A., Seravalli, I., Ciofi-Baffoni, S., Lenci, E., Trabocchi, A., Rusconi, S.
10.1101/2025.10.30.685646 — Posted: 2025-11-03
SARS-CoV-2 Variant-Dependent Alterations in Nasopharyngeal Microbiota and Host Inflammatory Response
Maulen, M., Pezoa-Soto, I., Leon, D., Dominguez, E. M., Martin, A. J., Diaz-Vasquez, W. A.
10.1101/2025.10.30.685528 — Posted: 2025-11-03
Increased Insulin Resistance and Hyperglycemia in Long COVID disease: A Systematic Review and Meta-Analysis
Almulla, A. F., Zhang, Y., Tunvirachaisakul, C., Carvalho, A. F., Maes, M.
10.1101/2025.11.01.25339290 — Posted: 2025-11-02
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination
Geers, D., Aguilar-Bretones, M., Zaeck, L. M., Gill, P. A., Gonzalez-Lopez, C., Handrejk, K., Tan, N. H., den Hartog, Y., Gommers, L., Bogers, S., Mykytyn, A. Z., Sablerolles, R. S. G., Goorhuis, A., Postma, D. F., Visser, L. G., Dalm, V. A. S. H., Lafeber, M., Kootstra, N. A., van Baarle, D., Haagmans, B. L., Koopmans, M. P. G., GeurtsvanKessel, C. H., van der Kuy, P. H. M., van Nierop, G. P., van Zelm, M. C., de Vries, R. D.
10.1101/2025.10.30.25339006 — Posted: 2025-11-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).